Research study Program year 2025 Source: CMS Open Payments

A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent A

Research payments

$838,204

372 payments

Through program year 2025, $838,204 in research payments was reported against A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent A, across 372 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$18,643	1
2024	Research	$62,421	35
2023	Research	$15,651	10
2022	Research	$88,114	39
2021	Research	$216,518	128
2020	Research	$403,407	156
2019	Research	$33,450	3

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $838,204 372 payments

Who received the money Research payments · program years 2019–2025

Wake Forest University Health Scien Organisation paid for research $99,338 58 payments
Orlando Immunology Center Organisation paid for research $66,657 32 payments
Indiana University Organisation paid for research $63,200 25 payments
Wake Forest Uni Health Science Organisation paid for research $59,067 13 payments
Carolina Ins For Clinic Research Organisation paid for research $52,322 48 payments
The Crofoot Research Center Organisation paid for research $49,880 11 payments
Palmtree Clinical Research INC Organisation paid for research $43,682 21 payments
Emory University Organisation paid for research $37,997 6 payments
Metrohealth System Organisation paid for research $25,312 7 payments
Infectious Disease Specialists Of Atlanta Pc Organisation paid for research $21,938 19 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.